CN101156939A - Medicine for treating tinea manuum - Google Patents
Medicine for treating tinea manuum Download PDFInfo
- Publication number
- CN101156939A CN101156939A CNA2006100693212A CN200610069321A CN101156939A CN 101156939 A CN101156939 A CN 101156939A CN A2006100693212 A CNA2006100693212 A CN A2006100693212A CN 200610069321 A CN200610069321 A CN 200610069321A CN 101156939 A CN101156939 A CN 101156939A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- medicine
- external
- tinea
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 58
- 206010067197 Tinea manuum Diseases 0.000 title claims abstract description 25
- 229940079593 drug Drugs 0.000 title description 6
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 29
- 238000002791 soaking Methods 0.000 claims abstract description 15
- 229910052957 realgar Inorganic materials 0.000 claims abstract description 14
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000011593 sulfur Substances 0.000 claims abstract description 10
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 10
- 238000011282 treatment Methods 0.000 claims description 20
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 8
- 241001161070 Calomela Species 0.000 claims description 8
- 241000529084 Epicauta gorhami Species 0.000 claims description 8
- 241000003857 Parmelia saxatilis Species 0.000 claims description 8
- 241000131808 Scolopendra Species 0.000 claims description 8
- 206010043866 Tinea capitis Diseases 0.000 claims description 8
- 229940025250 camphora Drugs 0.000 claims description 8
- 239000010238 camphora Substances 0.000 claims description 8
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 claims description 8
- 208000009189 tinea favosa Diseases 0.000 claims description 8
- 208000002474 Tinea Diseases 0.000 abstract description 10
- 208000003251 Pruritus Diseases 0.000 abstract description 7
- 231100000614 poison Toxicity 0.000 abstract description 7
- 201000004647 tinea pedis Diseases 0.000 abstract description 7
- 230000003902 lesion Effects 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 230000001954 sterilising effect Effects 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 5
- 239000003440 toxic substance Substances 0.000 abstract description 5
- 230000007803 itching Effects 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 4
- 230000001225 therapeutic effect Effects 0.000 abstract description 4
- 206010005913 Body tinea Diseases 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000035876 healing Effects 0.000 abstract description 3
- 230000001976 improved effect Effects 0.000 abstract description 3
- 201000003875 tinea corporis Diseases 0.000 abstract description 3
- 208000010195 Onychomycosis Diseases 0.000 abstract description 2
- 201000010618 Tinea cruris Diseases 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 238000005469 granulation Methods 0.000 abstract description 2
- 230000003179 granulation Effects 0.000 abstract description 2
- 230000035699 permeability Effects 0.000 abstract description 2
- 201000005882 tinea unguium Diseases 0.000 abstract description 2
- 241000893966 Trichophyton verrucosum Species 0.000 abstract 2
- 241000258920 Chilopoda Species 0.000 abstract 1
- 241000045019 Huechys sanguinea Species 0.000 abstract 1
- 241001676573 Minium Species 0.000 abstract 1
- 241001671204 Stemona Species 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 201000004624 Dermatitis Diseases 0.000 description 14
- 239000000843 powder Substances 0.000 description 7
- 208000025865 Ulcer Diseases 0.000 description 6
- 208000010668 atopic eczema Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 244000045947 parasite Species 0.000 description 6
- 231100000397 ulcer Toxicity 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 206010063409 Acarodermatitis Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000447727 Scabies Species 0.000 description 4
- 241000130764 Tinea Species 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 208000005687 scabies Diseases 0.000 description 4
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000124079 Mylabris Species 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 3
- 150000002460 imidazoles Chemical class 0.000 description 3
- 229960004130 itraconazole Drugs 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 230000001857 anti-mycotic effect Effects 0.000 description 2
- 239000002543 antimycotic Substances 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000001329 hyperkeratotic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229960002722 terbinafine Drugs 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 241000125147 Aethusa cynapium Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 206010012504 Dermatophytosis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000623906 Lytta vesicatoria Species 0.000 description 1
- 241001460074 Microsporum distortum Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229960004884 fluconazole Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 229940046892 lead acetate Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 206010025226 lymphangitis Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 231100000004 severe toxicity Toxicity 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides a medicament for treating tinea manuum, which belongs to a Chinese medicinal composition, comprising an external soaking agent and an external rubbing agent, wherein the external soaking agent is prepared from sting, huechys sanguinea, centipede, lichen, stemona root and the like according to a mixture ratio, the external rubbing agent is prepared from sulfur, realgar, minium, alum and the like according to a mixture ratio, the medicament can soften skin cuticle, enhance the killing and bacteriostasis capability of the medicaments on ringworm in the skin cuticle, improve blood circulation of lesions, eliminate toxic substances in the lesions, promote the absorption and healing of the lesions on the medicament, has strong killing capability on the ringworm, high permeability and greatly improved effects of sterilizing, relieving itching and removing putrefaction and promoting granulation, achieves the aim of clinically and completely curing the lesions, effectively overcomes the defect that the tinea manuum cannot be completely cured by using western medicines for a long time, the symptoms of patients are immediately relieved, more than 90 percent of the patients can be recovered, and has low recurrence rate, and good therapeutic effect on tinea pedis, tinea corporis, tinea cruris, and onychomycosis.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of the tinea manuum, especially a kind of animal kind medicine thing and minerals medicine with Chinese herbal medicine, Chinese medicine is the medicine that raw material is made.
Background technology
The tinea manuum (being commonly called as fungal infection of hand and foot) is that clinical dermatophytosis common and that heal than refractory infects.The tinea manuum is one-sided often, and tinea pedis often is a bilateral.The pathogenic bacterium of the tinea manuum are trichophyton more than 90%, are acrothesium floccosum, alpha fungus secondly.Be characterized in causing infection in the pathogenic bacterium intrusion human body skin horny layer, small number of patients can have tinea manus and pedis to exist simultaneously, but cross infection in the family, the M-F no significant difference.Tinea manuum patient's different times can a certain type be main, shows as the blister type summer, shows as hyperkeratotic pattern winter.And the tinea pedis patient generally is divided into three types, promptly vesicle type, hyperkeratotic pattern, invade the stain erosive type.And but tinea manus and pedis secondary bacterial infection suppurates, and ulcer, pruritus can cause lymphangitis, cellulitis or erysipelas unbearably, and focus pain redness influences limb activity.
At present, there are the following problems for the medicine of state's internal therapy tinea manuum:
1, Western medicine generally adopts external used medicines such as imidazoles solution or cream more when the treatment tinea manuum, simple external medication poor effect person, and oral antimycotic medicine, as itraconazole, terbinafine, fluconazol etc., life-time service is bigger to hepatorenal damage.
2, to secondary infection person with treatments such as 1/5000 potassium permanganate, 0.5% lead acetate, Radix Sophorae Flavescentis fluid, compound acidi salicylici unguentums, in the time of can not control infection, have only by the antibiotic auxiliary treatment.
3, the reason of the influence treatment tinea manuum is a lot.The Western medicine drug that uses at present clinical and some Chinese medicine preparation all exist the problem of curing the symptoms, not the disease, and treatment time is long, and misery is many, easily the shortcoming of recurrence.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of medicine for the treatment of the tinea manuum, to improve the effect of the treatment tinea manuum.
The present invention is achieved in that a kind of medicine for the treatment of the tinea manuum, and it comprises that external soaking agent and external are coated with the stranding agent, and the weight proportion of described external soaking agent is:
Class stings the 1.6-2.8 weight portion
Epicauta gorhami 1.6-2.8 weight portion
Scolopendra 0.5-1 weight portion
Parmelia saxatilis Ach. 30-40 weight portion
Radix Stemonae 10-15 weight portion
Cortex Pseudolaricis 10-15 weight portion
Fructus Cnidii 10-15 weight portion
Favus skin 10-15 weight portion;
Described external is coated with the weight proportion of rubbing agent with the hands:
Sulfur 40-45 weight portion
Realgar 4-10 weight portion
Plumbum preparatium 4-10 weight portion
Alumen 4-10 weight portion
Dried Alumen 4-10 weight portion
Cinnabaris 4-8 weight portion
Camphora 4-8 weight portion
Calomelas 2-4 weight portion.
Clinical use result shows that a kind of medicine for the treatment of the tinea manuum of the present invention has following advantage:
1, it adopts animal class, plant medicine thing as external soaking agent softening skin horny layer, strengthen between each medicine the killing and bacteriostasis of tinea bacterium in the keratodermatitis improved the focus blood circulation, remove the focus noxious substance, promote the absorption of focus, healing to medicine.
2, in the minerals medicine, selected the tinea bacterium is killed the medicine that ability is strong, penetration is high, organically combine between all medicines, further improved killing to the tinea bacterium, it is long to act on the focus time, and the effect of sterilizing and itch-relieving, putrefaction-removing granulation-promoting improves greatly, reaches the purpose of clinical thorough healing focus.
3, it has overcome the deficiency that the life-time service Western medicine can not thoroughly not cured the tinea manuum effectively, and after the patient used this medicine, symptom was alleviated immediately, and the patient more than 90% rehabilitates, and relapse rate is low.
4, the present invention's medicine is to tinea pedis, tinea corporis, and tinea cruris, tinea unguium also have excellent curative.
The specific embodiment
Further specify the present invention below
The preferred weight proportion of described external soaking agent is:
Class stings the 1.6-2.4 weight portion
Epicauta gorhami 1.6-2.4 weight portion
Scolopendra 0.5-1 weight portion
Parmelia saxatilis Ach. 30-40 weight portion
Radix Stemonae 10-15 weight portion
Cortex Pseudolaricis 10-15 weight portion
Fructus Cnidii 10-15 weight portion
Favus skin 10-15 weight portion;
Described external is coated with the preferred weight proportion of rubbing agent with the hands:
Sulfur 40-45 weight portion
Realgar 5-7 weight portion
Plumbum preparatium 5-7 weight portion
Alumen 5-7 weight portion
Dried Alumen 5-7 weight portion
Cinnabaris 5-7 weight portion
Camphora 5-7 weight portion
Calomelas 3-4 weight portion.
The preparation method of the present invention's medicine is, with the plant medicine thing in the external soaking agent disconnected broken be coarser powder, put into animal kind medicine thing dry sterilization together, the vacuum packet bag of packing into.External is coated with minerals medicine Realgar, the Cinnabaris rubbed with the hands in the agent grinds impalpable powder and cross the 100-120 mesh sieve, surplus medicine mixes to be ground into and is packaged into bag with Realgar, Cinnabaris powder mixing after impalpable powder is crossed the 100-120 mesh sieve.Every bag of weight is 40-50g.
It should be noted that Realgar, sulfur can not mix and grind, with blast protection.
The technical scheme of the present invention's medicine is treated the treatment rule of the medicine prescription and the treating the poisonous disease with poisonous drugs that motherland's therapeutic treatment stubborn dermatitis is adopted of various stubborn dermatitis with reference to Chinese medicine, used for reference handed down from the older generations of the family tinea name side and the effective folk prescription proved recipe controlled, in conjunction with the pharmacological research achievement of modern medicine to the treatment stubborn dermatitis, filter out the medicine that sterilizing power is strong, permeability is high, the bactericidal ability is strong meticulously, make the present invention's medicine have heat-clearing and toxic substances removing, dampness removing to stop itchin, putrefaction-removing granulation-promoting, the function of convergence wound surface impels focus to heal as early as possible.
The pharmacological effect of the raw material in the present invention's the medicine is:
1, Chinese blister beetle of class: the counteracting toxic substances phagedenoma cures mainly rabies, stubborn dermatitis, lymphoid tuberculosis.
2, Epicauta gorhami: blood circulation promoting and blood stasis dispelling, detoxifcation is stimulated the menstrual flow, and cures mainly dog poison, stubborn dermatitis malignant boil.
3, Scolopendra: relieving convulsion relieving dizziness, high fever, infantile convulsions, epilepsy, etc., dispersing pathogen accumulation cures mainly lymphoid tuberculosis, ulcer does not close up for a long time.
4, Parmelia saxatilis Ach.: clearing away heat-damp and promoting diuresis, external cure mainly eczema, exudative dermatitis.
5, the Radix Stemonae: the cough-relieving virus killing, external cures mainly skin scabies, eczema etc.
6, Cortex Pseudolaricis: clearing away heat-damp and promoting diuresis, killing parasites for relieving itching, external cures mainly various stubborn dermatitis.
7, Fructus Cnidii: removing dampness to relieve itching, external cure mainly tinea corporis, tinea manus and pedis, neurodermatitis.
8, favus skin: heat clearing and damp drying cures mainly skin pruritus, eczema, impetigo etc.
9, sulfur: relieving constipation parasite killing, external cure mainly scabies, seborrheic dermatitis, eczema.
10, Realgar: the detoxifcation parasite killing, external cures mainly scabies, herpes zoster, carbuncle etc.
11, Plumbum preparatium: removing toxic substances and promoting granulation, external cure mainly carbuncle ulcer, burn and scald etc.
12, Alumen: removing dampness and eliminating phlegm, killing parasites for relieving itching, the anticorrosion detoxicating of external etc.
13, dried Alumen: convergence skin ulcer face cures mainly eczema, ulcer suction inlet not for a long time.
14, Cinnabaris: relieving convulsion detoxifcation, treatment of ulcer toxic swelling etc.
15, Camphora: sensible parasite killing, external cure mainly beriberi, eczema scabies etc.
16, Calomelas: the counteracting toxic substances removing the necrotic tissue, parasite killing is held back skin ulcer, and external cures mainly carbuncle ulcer.
The using method of the present invention's medicine is: during the treatment tinea manuum, earlier the external soaking agent was soaked 1-2 hour with cold water, the water yield is crossed the both hands face with the energy submergence and is advisable, and boils and boils 10-15 minute, smoking the palm affected part of washing one's hands while hot, fully embathe to soak the cool reheat of water.Immersion finishes, and hands is wiped away dried, and conveniently humidity is coated with the last layer external equably and is coated with the stranding agent in the affected part, and thickness is about 0.5mm.Or with a little vaseline after the affected part is coated with stranding, the repaste last layer is coated with the stranding agent.A kind of with in 250w infrared lamp, all woods audiofrequency spectrometers, the charcoal fire, roasting affected part 30 minutes.To be coated with after 2 hours and rub agent with the hands with under the Warm Wash.Be coated with every day and rub agent 2-3 time with the hands.
Should note during use:
1, the external infusion is not outwelled after soaking and using.Every dose can be used 3-5 time repeatedly.During water shortage, can take the circumstances into consideration to add water.
2, external soaking agent, external are coated with the stranding agent all severe toxicity, can not be oral.As enter in the eye, clean repeatedly with cold water and get final product.
3. the external soaking agent is a course of treatment for 3 doses.Severe patient can increase by 2 doses.
4. infection focus is forbidden to use, and this medicine is corrosive, and can increase infection.Use this medicine best in the keratinization phase.
5. if any recurrence, once reusable, method is the same.
6. the careful usefulness of skin allergy person.
7. earlier the external soaking agent is boiled before the using medicinal liquid that boils and external is coated with and rubs agent with the hands and spread upon affected area, do not have irritated phenomenon in 12 hours after, can use.
It below is clinical observation material.
Clinical effectiveness for the medicine that shows the present invention, used the patient of imidazoles solution or cream external curing and oral antimycotic medicine such as itraconazole, terbinafin, the Fluconazole treating tinea manuum with 100 examples, contrasted with the patient of the Drug therapy of using the present invention.
Curative effect judging standard:
Cure, it is normal that lesions position skin recovers, and do not have recurrence more than 1 year.Effectively, recurrence in a year, but symptom is alleviated before the treatment greatly.Invalid, symptom does not have obvious change behind the use medicine.
Test group: 100 examples, male 54 examples, women 46 examples, age 18-65 year, the morbidity patient is the tinea manuum, and single bilateral all has.Administrated method is with above-mentioned.
Matched group: 100 examples, age, the state of an illness, routine number etc. are compared there was no significant difference with test group, and comparability is arranged.Administrated method: external imidazoles solution or cream, oral itraconazole 0.2-0.4g/ day, serve on a week at every day 2-3 time; Terbinafine 0.25g/ day, serve on a week; Fluconazol 0.15g/ time serve on 3-4 time.
Therapeutic effect sees the following form.
| Group | Total routine number | The routine number (accounting for the % of total routine number) of fully recovering | Effective routine number (accounting for the % of total routine number) | Invalid routine number (accounting for the % of total routine number) | Total effective rate (%) |
| Matched group | 100 | 0(0％) | 30(30％) | 70(70％) | 30％ |
| Test group | 100 | 90(90％) | 6(6％) | 1(1％) | 96％ |
Can represent that from last table the therapeutic effect of the present invention's medicine is better than the effect of Western medicine greatly.
Embodiment 1.
Join this and take by weighing raw material by following:
Mylabris 2.8g, Epicauta gorhami 2.8g, Scolopendra 0.6g, Parmelia saxatilis Ach. 30g, Radix Stemonae 10g, Cortex Pseudolaricis 10g, Fructus Cnidii 10g, favus skin 10g; Sulfur 40g, Realgar 6g, Plumbum preparatium 6g, Alumen 6g, dried Alumen 6g, Cinnabaris 4g, Camphora 4g, Calomelas 2g.
Breaking the plant medicine thing broken is coarser powder, puts into animal kind medicine thing dry sterilization final vacuum and be packaged into bag.Minerals medicine Realgar, Cinnabaris are ground impalpable powder spend 100-200 day and sieve, surplus medicine is packaged into bag with Realgar, Cinnabaris powder mixing after mixing and grinding 100 mesh sieves.Every bag heavy 50g.
Embodiment 2
Join this and take by weighing raw material by following:
Mylabris 2.4g, Epicauta gorhami 2.4g, Scolopendra 0.8g, Parmelia saxatilis Ach. 35g, Radix Stemonae 12g, Cortex Pseudolaricis 12g, Fructus Cnidii 12g, favus skin 12g; Sulfur 42g, Realgar 8g, Plumbum preparatium 8g, Alumen 8g, dried Alumen 8g, Cinnabaris 6g, Camphora 6g, Calomelas 3g.Preparation method is the same.
Embodiment 3
Join this and take by weighing raw material by following:
Mylabris 2g, Epicauta gorhami 2g, Scolopendra 1g, Parmelia saxatilis Ach. 40g, Radix Stemonae 15g, Cortex Pseudolaricis 15g, Fructus Cnidii 15g, favus skin 15g; Sulfur 45g, Realgar 10g, Plumbum preparatium 10g, Alumen 10g, dried Alumen 10g, Cinnabaris 8g, Camphora 8g, Calomelas 4g.Preparation method is the same.
Claims (2)
1. a medicine for the treatment of the tinea manuum is characterized in that, it comprises that external soaking agent and external are coated with the stranding agent, and the weight proportion of described external soaking agent is:
Class stings the 1.6-2.8 weight portion
Epicauta gorhami 1.6-2.8 weight portion
Scolopendra 0.5-1 weight portion
Parmelia saxatilis Ach. 30-40 weight portion
Radix Stemonae 10-15 weight portion
Cortex Pseudolaricis 10-15 weight portion
Fructus Cnidii 10-15 weight portion
Favus skin 10-15 weight portion;
Described external is coated with the weight proportion of rubbing agent with the hands:
Sulfur 40-45 weight portion
Realgar 4-10 weight portion
Plumbum preparatium 4-10 weight portion
Alumen 4-10 weight portion
Dried Alumen 4-10 weight portion
Cinnabaris 4-8 weight portion
Camphora 4-8 weight portion
Calomelas 2-4 weight portion.
2. the medicine of the treatment tinea manuum as claimed in claim 1 is characterized in that, the weight proportion of described external soaking agent is:
Class stings the 1.6-2.4 weight portion
Epicauta gorhami 1.6-2.4 weight portion
Scolopendra 0.5-1 weight portion
Parmelia saxatilis Ach. 30-40 weight portion
Radix Stemonae 10-15 weight portion
Cortex Pseudolaricis 10-15 weight portion
Fructus Cnidii 10-15 weight portion
Favus skin 10-15 weight portion;
Described external is coated with the weight proportion of rubbing agent with the hands:
Sulfur 40-45 weight portion
Realgar 5-7 weight portion
Plumbum preparatium 5-7 weight portion
Alumen 5-7 weight portion
Dried Alumen 5-7 weight portion
Cinnabaris 5-7 weight portion
Camphora 5-7 weight portion
Calomelas 3-4 weight portion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2006100693212A CN101156939B (en) | 2006-10-06 | 2006-10-06 | A medicine for treating tinea manuum |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2006100693212A CN101156939B (en) | 2006-10-06 | 2006-10-06 | A medicine for treating tinea manuum |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101156939A true CN101156939A (en) | 2008-04-09 |
| CN101156939B CN101156939B (en) | 2011-06-08 |
Family
ID=39305261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2006100693212A Expired - Fee Related CN101156939B (en) | 2006-10-06 | 2006-10-06 | A medicine for treating tinea manuum |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101156939B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101401822B (en) * | 2008-11-11 | 2011-03-23 | 张�林 | General medicinal powder for treating beriberi, foot corn and callus on the sole |
| CN103735582A (en) * | 2014-01-02 | 2014-04-23 | 姬泽木 | Traditional Chinese medicine for treating psoriasis and preparation method of tradition Chinese medicine |
| CN105343423A (en) * | 2015-11-26 | 2016-02-24 | 姜义祥 | Eczema treatment medicine and preparation method thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1047080C (en) * | 1989-05-13 | 1999-12-08 | 程立志 | Process for preparing medicine to inhibit skin itch |
| CN1304734A (en) * | 2000-11-08 | 2001-07-25 | 赖德明 | Liniment for treating dermatopathy |
| CN1481880A (en) * | 2003-07-10 | 2004-03-17 | 姜延德 | Ointment for curing tinea on manus and pedes |
| CN1768841A (en) * | 2005-10-27 | 2006-05-10 | 湖北鼎龙制药有限公司 | Chinese medicinal compound formulation for treating skin disease |
-
2006
- 2006-10-06 CN CN2006100693212A patent/CN101156939B/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101401822B (en) * | 2008-11-11 | 2011-03-23 | 张�林 | General medicinal powder for treating beriberi, foot corn and callus on the sole |
| CN103735582A (en) * | 2014-01-02 | 2014-04-23 | 姬泽木 | Traditional Chinese medicine for treating psoriasis and preparation method of tradition Chinese medicine |
| CN105343423A (en) * | 2015-11-26 | 2016-02-24 | 姜义祥 | Eczema treatment medicine and preparation method thereof |
| CN105343423B (en) * | 2015-11-26 | 2018-12-25 | 姜义祥 | A kind of drug and preparation method thereof for treating eczema |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101156939B (en) | 2011-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101703732B (en) | Chinese medicinal ointment for treating herpes zoster and preparation method thereof | |
| CN1872235A (en) | Muskiness acesodyne ointment of chasing wind, and preparation method | |
| CN101156939B (en) | A medicine for treating tinea manuum | |
| CN103055222A (en) | Medicine for treating tinea manus and pedis | |
| CN101167855B (en) | Medicine for treating tinea pedis and tinea manuum | |
| CN102755573A (en) | External use traditional Chinese medicine for treating onychomycosis | |
| CN1177599C (en) | Chinese medicine for treating burn and scald and its preparing process | |
| CN102847109B (en) | Navel-applied plaster for treating dysmenorrhea and preparation method thereof | |
| CN105362349A (en) | Traditional Chinese medicine external-use lotion for treating palmoplantar eczema and nursing method | |
| CN102961511A (en) | Medicine for treating paronychia and preparation method for same | |
| CN108771722A (en) | A kind of Ji Shi channels sootheing and network vessel quickening thermal therapy patchs for treating neck-shoulder pain, lumbago and leg pain and rheumatism bone disease | |
| CN101559125B (en) | Burning powder | |
| CN1259087C (en) | Medicine for treating trauma and sores and its preparing process | |
| CN1772127A (en) | Detoxicating and blood circulation promoting ointment and its prepn | |
| CN104288597B (en) | A kind of Chinese medicine composition for treating herpes zoster | |
| CN105343277A (en) | Skin-nursing traditional Chinese medicine ointment for treating tinea versicolor and preparation method of skin-nursing traditional Chinese medicine ointment | |
| CN101332261B (en) | External medicine for treating furunculosis | |
| CN112915152B (en) | Traditional Chinese medicine mask for treating rash related to tumor molecule targeted medicine and preparation method thereof | |
| CN101940652A (en) | Chinese medicinal liniment for treating psoriasis, multiple kinds of stubborn dermatitis and pruritus | |
| CN102973630B (en) | Traditional Chinese medicine combination and preparation method thereof | |
| CN107625822A (en) | A kind of Chinese medicine composition for treating tuberculosis, preparation technology and application | |
| CN102755477A (en) | Externally-used plaster for treating onychomycosis | |
| CN101647886A (en) | Traditional Chinese medicine formula of medicinal powder for treating burns in externally-applied way | |
| CN107684605A (en) | A kind of Chinese medicine composition for treating anaphylaxis dermatosis and preparation method thereof | |
| CN109865037A (en) | A kind of external drug and preparation method thereof for treating surgery pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| ASS | Succession or assignment of patent right |
Owner name: LIU BAOHUAN Free format text: FORMER OWNER: DONG JISHENG Effective date: 20090828 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20090828 Address after: Wuli People's Hospital,, Wudi County, Binzhou, Shandong Province, China 187 Applicant after: Liu Baohuan Address before: The 104 oil production team of No. 1 oil production well in Du Zhen Town, Shandong City, Binzhou Province Applicant before: Dong Jisheng |
|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110608 Termination date: 20111006 |